Welcome to LookChem.com Sign In|Join Free

CAS

  • or

154748-49-9

Post Buying Request

154748-49-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

154748-49-9 Usage

Form

Solid

Uses

tert-Butyl (3-Oxocyclobutyl)carbamate is used in the preparation of 5-HT1-like receptor agonists. It is also used to synthesize (oxadiazolyl)quinoline derivatives as highly potent HCV NS4B inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 154748-49-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,7,4 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 154748-49:
(8*1)+(7*5)+(6*4)+(5*7)+(4*4)+(3*8)+(2*4)+(1*9)=159
159 % 10 = 9
So 154748-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H15NO3/c1-9(2,3)13-8(12)10-6-4-7(11)5-6/h6H,4-5H2,1-3H3,(H,10,12)

154748-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl 3-oxocyclobutylcarbamate

1.2 Other means of identification

Product number -
Other names 3-(tert-Butoxycarbonylamino)-1-cyclobutanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:154748-49-9 SDS

154748-49-9Downstream Products

154748-49-9Relevant articles and documents

Preparation method of tert-butyl 3-oxocyclobutyl carbamate

-

Paragraph 0046-0047, (2020/11/12)

The invention belongs to the technical field of medicines, and particularly relates to a preparation method of tert-butyl 3-oxocyclobutyl carbamate (I). The method comprises the following steps: protecting a compound IV to generate a compound III, carrying out Hofmann degradation reaction to obtain a compound II, and finally, carrying out deprotection to obtain a compound I. Compared with the prior art, the method is low in technical route cost and mild in reaction condition, avoids the use of toxic reagents with larger danger coefficients, is green and environment-friendly, and has good application value.

Novel CDK inhibitory compounds, preparation method thereof, pharmaceutical composition for use in preventing or treating CDK relating diseases containing the same as an active ingredient

-

Paragraph 0287-0290, (2018/10/24)

The present invention relates to a novel CDK inhibitory compound, a method for manufacturing the same, and a pharmaceutical composition for preventing or treating a CDK-related disease containing the compound as an active ingredient. The novel CDK inhibit

METHODS OF TREATING PULMONARY DISEASES AND DISORDERS

-

Paragraph 0117; 0250, (2017/07/14)

The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 154748-49-9